1. Home
  2. SONM vs PHGE Comparison

SONM vs PHGE Comparison

Compare SONM & PHGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SONM
  • PHGE
  • Stock Information
  • Founded
  • SONM 1999
  • PHGE 2015
  • Country
  • SONM United States
  • PHGE Israel
  • Employees
  • SONM N/A
  • PHGE N/A
  • Industry
  • SONM Telecommunications Equipment
  • PHGE Biotechnology: Pharmaceutical Preparations
  • Sector
  • SONM Telecommunications
  • PHGE Health Care
  • Exchange
  • SONM Nasdaq
  • PHGE Nasdaq
  • Market Cap
  • SONM 12.1M
  • PHGE 12.6M
  • IPO Year
  • SONM 2019
  • PHGE N/A
  • Fundamental
  • Price
  • SONM $0.73
  • PHGE $0.58
  • Analyst Decision
  • SONM
  • PHGE Strong Buy
  • Analyst Count
  • SONM 0
  • PHGE 1
  • Target Price
  • SONM N/A
  • PHGE $15.00
  • AVG Volume (30 Days)
  • SONM 1.6M
  • PHGE 344.1K
  • Earning Date
  • SONM 11-12-2025
  • PHGE 11-13-2025
  • Dividend Yield
  • SONM N/A
  • PHGE N/A
  • EPS Growth
  • SONM N/A
  • PHGE N/A
  • EPS
  • SONM N/A
  • PHGE N/A
  • Revenue
  • SONM $57,917,000.00
  • PHGE N/A
  • Revenue This Year
  • SONM $127.68
  • PHGE N/A
  • Revenue Next Year
  • SONM N/A
  • PHGE N/A
  • P/E Ratio
  • SONM N/A
  • PHGE N/A
  • Revenue Growth
  • SONM N/A
  • PHGE N/A
  • 52 Week Low
  • SONM $0.52
  • PHGE $0.34
  • 52 Week High
  • SONM $6.38
  • PHGE $1.16
  • Technical
  • Relative Strength Index (RSI)
  • SONM 52.92
  • PHGE 58.47
  • Support Level
  • SONM $0.59
  • PHGE $0.50
  • Resistance Level
  • SONM $0.77
  • PHGE $0.60
  • Average True Range (ATR)
  • SONM 0.07
  • PHGE 0.03
  • MACD
  • SONM 0.00
  • PHGE 0.01
  • Stochastic Oscillator
  • SONM 35.95
  • PHGE 70.84

About SONM Sonim Technologies Inc.

Sonim Technologies Inc is a provider of ultra-rugged mobile devices, including phones and accessories designed specifically for task workers physically engaged in their work environments, often in mission-critical roles. The company sells mobile phones, accessories, and solutions to AT&T, T-Mobile, and Verizon in the Canada, and to Bell, Rogers, and Telus and Rogers, Telstra in Australia. The products include rugged mobile phones that can attach to both public and private wireless networks, industrial-grade accessories that meet the requirements of specific applications and software applications, and cloud-based tools that provide management and deployment services to customers. The company generates revenue from discounts, price protection, and customer incentives.

About PHGE BiomX Inc. COmmon Stock

BiomX Inc is engaged in developing both natural and engineered phage cocktails and personalized treatments designed to target and destroy harmful bacteria in chronic diseases, including cystic fibrosis and diabetic foot osteomyelitis. It discovers and validates proprietary bacterial targets and customizes phage compositions against these targets, and applies its BOLT (BacteriOphage Lead to Treatment) platform to customize phage compositions against these targets. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF. Its BX211 - Treatment of Diabetic Foot Osteomyelitis (DFO).

Share on Social Networks: